Science & Engineering Research Council Sponsored 4th International conference on PPDDDCT at Chitkara College of Pharmacy
Chitkara College of Pharmacy was started in 2005 by the Chitkara Education Trust, Chandigarh, under the guidance of renowned academicians Dr. Ashok Chitkara and Dr. (Mrs.) Madhu Chitkara. Chitkara Educational group campus is located at Jhansla, Rajpura and the campus has institutions including Chitkara College of Pharmacy, Chitkara Institute of Engineering and Technology, Chitkara School of Planning and Architecture, Chitkara School of Education, Chitkara School of Hospitality Management, Chitkara Business School. The different institutes have relevant accreditations including National Councils, ISO and NAAC. The campus is hosting degree and Post degree level courses in Pharmacy, Electrical Engineering, Computer Science and Engineering, Electronics and Communication Engineering and Mechanical Engineering, Architecture, Education, Management, Media and Health Sciences. Chitkara College of Pharmacy has courses B. Pharm, M. Pharm, Pharm D and Ph. D approved by AICTE, PCI & UGC and affiliated to Chitkara University, Punjab. The institute has highly qualified faculty, well equipped laboratories, high speed internet facility and a very well equipped library. The college has comprehensive research portfolios with more than 10 patents, 200 publications, 100 PG thesis and Ph.D program going for making it a premier centre for higher education in Pharmaceutical Sciences.
OBJECTIVE OF THE CONFERENCE:
Science & Engineering Research Council Sponsored 4th International conference, being the most innovative event, aims to provide an open and stimulating scientific and cultural exchange that will give all the participants the opportunity to share their experiences, foster collaborations across industry and academia and evaluate emerging technologies across the globe. The process of drug discovery is quite complex, integrating many disciplines, including structural biology, metabolomics, proteomics, and computer science. The process of drug discovery involves the identification of candidates, synthesis, characterization, screening, and assays for therapeutic efficacy. Drug discovery and development process is generally quite tedious and expensive. Drug targets are usually proteins, either those occurring within the human body of in outside agents such as viruses and other pathogens.The major difficulty faced by drug researchers is understanding the complex chemical pathways involved in the disease process in order to find the most appropriate intervention point, and then to discover or design a compound that modifies the chemical process at that point. Advancements in Genomics and Proteomics, together with integrating myriad disciplines from structural biology to computer sciences, have brought tremendous change in the drug discovery process over the last few years. Mechanistic understanding of the nature of disease, novel biomarkers as diagnostic tools, target-specific molecules and integrated automated discovery platforms have become contemporary to the modern drug discovery process. The event will offer definite advantage to the researchers in the fields of Functional Genomics, Genomic Biomarkers, Epigenetics, Next-Generation Sequencing, miRNA and Non-coding RNA, qPCR, Bioinformatics, Proteomics and Proteome Analysis including Chromatography, Mass Spectroscopy and Lab Automation. The program will consist of moderated sessions and engaging an expert panel on research themes at the core of genomics, proteomics, drug discovery, development and clinical therapeutics.
MAIN CONFERENCES FEATURES
A. Symposia and Plenary/oration lectures
B. Poster/Oral Sessions
C. Prize sessions for Best Poster and Oral Presentations.
• Enable participants to exchange ideas and expand network with leading pharmaceutical scientists, clinicians and internists.
• Bring together top international scientists and clinicians presenting cutting-edge discoveries, research and new therapeutic drugs.
• Fourth international series of conferences to span interdisciplinary fields of pre- clinical and clinical drug discovery and drug therapy.
• Enable exhibitors to have increased visibility through branding and networking at the conference and gain direct access to a core audience of professionals and decision makers.
• Features a prolific commercial exhibition and poster sessions.
• Enable participants to obtain Continuing Medical Education accreditation for selected attended clinical lectures.
The conference will attract a targeted group of scientists and senior international decision maker. Delegate and exhibitors will have a valuable, informative and positive experience
- Pharmaceutical Scientists
- Medical Students
- CEOs, CROs senior instrumental professionals Directors and research associates from the Pharmaceutical industry and academia.
The research abstract should be structured as per the presented format. It should be complete with the subheadings- Title, Author’s name, Affiliation, Address with Email I.d and Phone number. The TITLE should be written in capitals. Name of authors should start with full name followed by surname. List no more than 5 authors. Underline/Highlight the name of presenting author and mark with asterix. The main body of the abstract should not exceed 250 words and must be prepared in a standard format with clearly outlined. Abstract should be divided into following parts Objectives/Aims, Methods, Results and Conclusions. References are not needed for abstracts. Incomplete abstracts or those not appropriately structured will be rejected. Type in single space with font Times new Roman and letter size 12 in the Abstract. Use high quality black inkjet or laser printing or electronic typing only. Handwritten abstracts cannot be accepted. Research work based abstracts / presentations will be given a high priority. Acceptance of the Abstracts will be notified by email by 10 March,2016. However, the acceptance will be provisional until the registration fee is not deposited by 10 March, 2016 essentially in the form of a Demand Draft in the favor of “Chitkara College of Pharmacy, Rajpura” payable at Chandigarh.
Abstracts can be submitted online to: firstname.lastname@example.org
All submitted conference papers will be blind peer reviewed by three competent reviewers. The post conference proceedings will be published in the international “Journal of Pharmaceutical Technology, Research and Management”. The conference proceedings book & CD and certificate of presentation will be distributed to the conference participants at the conference registration desk. Abstracts for all Seminar presentations will be published as the Proceedings of the Seminar. The Program Committee will select some presentations for the oral program from the submitted abstracts and will notify those authors. Other submissions will be offered poster presentation. Publication of selected abstracts as full papers in “Journal of Pharmaceutical Technology, Research and Management” are being brought out from Chitkara University, Punjab: Selected papers will be published in “Journal of Pharmaceutical Technology, Research and Management” for which submission guidelines for the Journal will be informed.
Prof Dr Ashok Chitkara
Chitkara University, Punjab
Professor(Dr.) Madhu Chitkara
Chitkara University, Punjab
Professor (Dr.) S. Arora,
Chitkara College of Pharmacy,
Chitkara University, Punjab
Dr Manoj K. Bhasin, Ph.D.
Assistant Professor of Medicine,
Harvard Medical School (HMS),USA
Dr Oliver Grundmann, PhD, MS
University of Florida, USA.
Dr. Thakur Gurjeet Singh
Associate Professor & HOD
Department of Pharmacology and Pharmacy Practice,
Chitkara College of Pharmacy, Chitkara University, Punjab
Deadline for registration and abstract submission: 10th March, 2016
Science & Engineering Research Council Sponsored
“Pharmacogenomics, proteomics in Drug Discovery,
development and clinical Therapeutics"
13th and 14th April, 2016
FIND MORE CONFERENCES AT PHARMATUTOR